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Abstract
Aim – improve the results of the treatment of patients with pulmonary bleeding through widespread use of endovascular surgery 
methods for hemostasis.
Materials and methods. Method of endovascular embolization of bronchial arteries is widely used in our clinic SI «Zay-
cev V. T. Institute of General and Emergency surgery of NAMS of Ukraine» not only as independent surgery in patients with LB, but 
also as way of preparation of patients with lung bleeding for planned thorax surgery. The most of the often spread nosological forms 
complicated by bleeding in our research were polycystic lung disease, chronic obstructive pulmonary disease, bronchiectasis disease, 
community-acquired pneumonia. Indications to the сatheter embolization procedure of bronchial arteries are the following: conser-
vative treatment failure, hemoptysis in patients with bilateral inflammatory processes who was not prescribed surgical treatment for 
a range of reasons, absence of gross structural changes, lung resection, mainly in patients with oncologic lung injury, at massive and 
life-threatening profuse bleedings as a mean of temporary or constant hemostasis. Discussed treatment method is applied only in bleed-
ing or within a 6–12 hour after its treatment. Successful result in embolization can be obtained in 79–99 %.
Results. As a result of complete physical examination of patients with LB, it has been established that lung hemorrhage was the 
result of obstructive bronchitis in 14 patients (42 %), there was chronic obstructive pulmonary disease in 7 (21 %) patients and bronchi-
ectasis was diagnosed in 6 (18 %) patients. In 2 (6 %) patients pulmonary hemorrhage was caused by community-acquired pneumonia. 
Central lung cancer was detected in 4 (12 %) patients.
Conclusion. Therefore bronchial artery angiography gives high efficiency in solving the problem of hemostasis in oncological 
and nonspecific lung diseases, for determination of localization and source of bleeding. Endovascular occlusion of bronchial arteries in 
pulmonary hemorrhage permits:
– to elaborate diagnosis because of the presence of specific angiographic signs of malignant tumour; 
– to perform effective endovascular hemostasis; 
– to gain time for stabilization the patient with the aim of planned surgical treatment.
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Treatment of pulmonary bleeding is still one of the most pressing problems in surgery. 
Pulmonary bleeding is the most dangerous complication of a number of diseases [1, 2]. There are 
40 nosological forms that can be complicated by pulmonary hemorrhage (PH); some authors de-
scribe PH as a complication in more than 100 diseases [3, 4]. Over the last decade, the role of 
obstructive and purulent pulmonary diseases, which significantly suppressed pulmonary tubercu-
losis, has increased in the emergence of pulmonary bleeding (PB) [5, 6]. 
Pulmonary bleeding is often a complication of various respiratory system diseases that 
are associated with the inflammatory process, which are found in 8–17 % of hospitalized patients 
[7, 8]. Most authors believe that in 95–98 % of observations the source of pulmonary bleeding 
in patients is bronchial arteries, which depart from the aorta and pleura [9, 10]. A consider-
able amount of surgical remedies to combat this threatening complication often complicates the 
choice of optimal treatment tactics and leads to the expansion of indications for the further im-
plementation of surgical interventions, which may adversely affect the expected results of treat-
ment and rehabilitation of patients in the early and long periods [11]. Despite certain advances in 
surgical treatment of pulmonary hemorrhage, which is associated with the use in the treatment 
of endovascular technologies, the mortality rate is still quite high, according to various authors, 
ranges from 15.1 % to 57.0 % [12, 13]. 
To date, X-ray vascular occlusion (REO) of the bronchial arteries allows patients to avoid 
surgery at the height of bleeding. Despite the fact that this method has been used in clinical prac-
tice for more than 30 years, the questions concerning the tactics of interventions and the choice of 
embolizing materials [14, 15]. Efficiency of the method in the long-term period is devoted to the 
publications. In particular, in young patients, pulmonary hemorrhage may be the first sign of the 
disease, while the lungs may lack morphological changes in the lung tissue [16, 17].
Currently, a large number of researchers believe that urgent surgery should be performed 
at the height to PB in the absence of the effect of conservative treatment. X-ray vascular occlusion 
(REO) of the bronchial arteries allows patients to avoid surgery at the height to bleeding. A signif-
icant addition to the arsenal of methods of surgical treatment of pulmonary hemorrhage was made 
by intervention radiology. Among these treatments, traumatic X-ray and vascular interventions are 
becoming increasingly important [8].
The use of the achievements of interventional radiology and the use of modern endovascular 
catheter technologies in surgery in the late XX ‒ early XXI centuries allowed to introduce a more 
advanced approach to the diagnosis and treatment of pulmonary bleeding [19]. Based on the level of 
development of interventional radiology in Ukraine, X-ray and vascular the rapies for the treatment 
of pulmonary hemorrhages of different etiology have not yet become widespread due to the lack of 
angiographic equipment in most clinics to provide highly qualified X-ray surgical care. The aim of 
the study. Improving the treatment of patients with pulmonary hemorrhage through widespread use 
of hemostasis for endovascular surgery [20, 21].
The aim of the research – improve the results of the treatment of patients with pulmonary 
bleeding through widespread use of endovascular surgery methods for hemostasis.
2. Materials and methods
The study was conducted at the Department of thoraco-abdominal surgery of SU
“Zaycev V. T. Institute of General and Emergency surgery of NAMS of Ukraine”. We 
examined 81 patients with lung bleeding of different etiology, who were hospitalized in the 
Department of thoraco-abdominal surgery. All patients were divided into two groups – of the 
main group 45 patients and the comparison group 36 patients, depend of ages, sex, nosological 
form, level of lung bleeding. Patients aged from 25 to 82 years, including 51 men (62.5 %) and 
30 women (37.5 %). The test diseases includes: bronchiectasis disease – in 29 (36.1 %), pulmo-
nary fibrosis with malformation BA – in 30 (37.3 %), abscess of the lung – in 11 (13.1 %), poly-
cystic lung disease – in 5 (6.1 %), chronic obstructive pulmonary disease – in 6 (7.4 %).
All patients were examined in accordance with the quality standards of the diagnostics. The 
diagnosis of the underlying disease was determined on the basis of general clinical examination, 
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instrumental and laboratory methods. The clinical diagnostic criteria for LB included the check of 
hemoglobin level and blood pressure. 
Roentgen-endovascular embolization of bronchial arteries was performed using and Phil-
lips Integris Allura 12C (Holland). Bronchial artery angiography consists of the following: fem-
oral catheterization was done by Seldinger technique under topical anesthesia (0.25 % solution of 
novocaine). Сateterization was performed by Cobra catheter with flexure 45–65 degrees. Catheter 
was inserted at T4-T5 level under control of monitor and then it is fixed in the bronchial artery 
or intercostal artery mouth by rotational movement of guide. 1 ml of contrast agent was added 
for monitoring of catheter location in required vessel. Polyurethane emboli having diameters of 
450–720 mm were used for embolization. Emboli in combination with microembols were inserted 
at a big diameter of pathologically changed vessel that enhances effect of embolization. Absence 
of inflow of contrast agent and enhancement of distal part of bronchial arteries were considered as 
criteria of effective embolization. 
Statistical comparisons were conducted using Student’s t-test statistically significant at 
p<0.05. Fisher’s angular transformation. The calculations were performed using software STATIS-
TICA for Windows and Microsoft Excel 10.0. 
3. Results
Immediate positive full effect of REEBA in the form of a complete stop bleeding was ob-
served in 78 (89.8±1.2 %, p≤0.05) patients. Other authors perceived similar efficiency of endovas-
cular hemostasis [22, 23]. Late relapses of LB and blood coughing was observed in 17 (20±2.1 %, 
p≤0.05) of patients [24].
Treatment of patients was started from the hemostatic therapy: 5 % solution of EACA, 
solution of sol. ethamsylati, dicynoni, sol. vicasoil, tranexamic acid. In patients with pulmonary 
hemorrhage of II grade, performed hemostatic therapy was added with introduction of albumin 
solution, fresh frozen plasma. Packed red cell transfusion was prescribed patients with pulmonary 
hemorrhage of III severity. Pulmonary hemorrhage was stopped in 14 (42±2.9 %, p≤0.001) with the 
use of roentgen-endovascular hemostasis of bronchial arteries (Fig. 1). High efficiency of roent-
gen-endovascular occlusion in pulmonary hemorrhage of different etiology was noted by majority 
of authors. Recurrence of bleeding in the long period after REO appeared in 2 (6.0±1.1 %, p≤0.001) 
inoperable patients with bronchiectasis disease.
Fig. 1. Angiography of patient with bronchiectatic disease complicated by lung bleeding from 
bronchial artery
Classification of pulmonary hemorrhages proposed by Grigoryev E.G., 1983 1 grade – he-








pulmonary hemorrhage: 2a – 30 – 200 ml per hour; 2b – 200 – 500 ml per hour. 3 grade – profuse 
pulmonary hemorrhage: 3a – 100 ml per saltum; 3b – more than 100 ml per saltum + obstruction of 
tracheobronchial tree, asphyxia. Classification depending on the extent of blood loss: 1. minor pulmo-
nary hemorrhage – from 50 to 100 ml per day; middle pulmonary hemorrhage – from 100 to 500 ml 
per day; 2. severe pulmonary hemorrhage – more than 500 ml per day; 3. extra severe, profuse pul-
monary hemorrhage – more than 500 ml per day; 4. bleeding arising per saltum or for a short period. 
Small LB and blood coughing was detected in 15 (18.8±2.2 %, p≤0.001) patients, medium 
and massive with highlight more than 200 ml of blood – in 9 (11.0±1.8 %, p≤0.001). Full treat-
ment after REE of bronchial arteries radical no operation was possible in 2 (0.47 %) patients. 
Required complex examination of patients turned on a computer tomography of organs of the 
chest cavity and bronchofibroscopy. The use of these methods allowed pain most observations 
set side of defeat [24].
Upon identification pathologically effected BA (bronchial artery), by exercising neck their 
blood supply, in BA to the conductor as distally as possible a working catheter was inserted. A 
catheter was inserted through polyurethane emboli with a diameter 400–750 microns. Embolysis 
control on was carried out by contrast BA, revealed its stump and 40 lack of admission contrast 
substance in the distal sections [26]. With a pathological change in BA, increase in diameter, avail-
ability malformations polyurethane embolis, gelatine embolis combined with the introduction of 
microspirals whose use allowed to reliably close the extended BA test. With the powered by lung 
parenchyma view and the presence of clots in the respirator paths after roentgen-endovascular em-
bolization of bronchial arteries carried out rehabilitation bronchofibroscopy combined with a short 
course antibacterial therapy and prescribe drugs to relieve pain [26, 27].  
4. Discussion
The materials used by the specialized department of thorax of the SI «Zaycev V. T. Institute 
of General and Emergency surgery of NAMS of Ukraine». In accordance with the set tasks, com-
plex clinical and laboratory, instrumental examination and treatment of 97 patients with pulmonary 
hemorrhages of different etiology were performed. After analysis of the obtained data from the 
examination and treatment of patients in the main group and the comparison group, it can be noted 
that properly organized conservative treatment of pulmonary hemorrhage using minimally inva-
sive technology is, in most cases, quite effective and avoids severe, sometimes lethal, complications 
that are almost inevitable for surgery performed at the height of pulmonary hemorrhages (Fig. 2). 
Our studies have allowed us to determine the following indications for X-ray vascular occlusion in 
pulmonary hemorrhage: 
1. Pulmonary bleeding in inoperable patients with inflammatory diseases of the lungs and 
bronchi. 
2. Pulmonary hemorrhage in operable patients to stabilize the patient, in-depth clinical ex-
amination and reduce operative blood loss. 
3. Pulmonary hemorrhage in limited fibrotic processes, clinical manifestations of which are 
expressed only by hemorrhage, and resection surgery is ineffective because of the possible risk. 
4. Prolonged postoperative intra-pleural bleeding with undetected source localization, 
recurrent hemorrhages from operated lungs to preserve lung function and to prevent recurrent 
operations. 
The absolute contraindications to the performance of radiographic occlusion were con-
sidered: cerebral coma, severe degree of hepatic-renal failure, unreliable catheter fixation in the 
vessel, incompatibility of the occlusive substances and anatomical features of the vessels to be 
excluded. The relative contraindications were pronounced intolerance of iodine-containing drugs, 
doubtful REO at high risk of intervention, age of the patient.
Among 45 patients with pulmonary hemorrhages, 37 (58.7 %) were treated only conserva-
tively. One of the main components of conservative treatment of pulmonary hemorrhage in patients 
of the main group was artificial controlled hypotension, whose main purpose was to reduce the 
initial blood pressure by 30‒40 mm Hg., which in turn reduced the intensity of blood loss and 
increased the effect of hemostatic drugs.
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Thus, the majority of patients admitted to the clinic with different types of pulmonary hem-
orrhages were cured by a complex of conservative measures without resorting to surgical methods 
of treatment. This group consisted mainly of patients with small short-term bleeding, which was 
not accompanied by a decrease in blood pressure and a decrease in the amount of hemoglobin (pul-
monary bleeding I–II severity).
Fig. 2. Quantitative correlation of the results of conservative and surgical treatment in patients 
with lung hemorrhage 
Our research suggests that bronchoscopic examination of patients with pulmonary hemor-
rhages is one of the leading and reliable diagnostic methods. The results of diagnostic and therapeu-
tic bronchoscopies in 53 patients indicate the safety and high informative content of this study. In 
addition to diagnostic capabilities, we have used bronchoscopy to perform a number of therapeutic 
hemostatic manipulations, in particular, endobronchial occlusions. The bleeding bronchial obstruc-
tion, first allows stopping blood flow to a tracheobronchial tree, to avoid aspiration and inflamma-
tory complications, and allows to carefully repair bronchial tubes and to provide improvement of 
ventilation of lung .
In our opinion, endobronchial occlusion is an important step in the preoperative preparation 
of the patient. Due to the filling of the bronchus, it is possible to achieve a temporary discontinu-
ation of the LB, which makes it possible to fully examine the patient, to determine the cause and 
source of bleeding, to correct disorders caused by the main disease and blood loss, to choose the 
optimal timing and type of further surgical treatment.
Bronchial occlusion in our observations was performed in 12 (19.1 %) patients and lasted 
from 5 to 7 days, the maximum term – 9 days. We did not observe any complications in the form 
of exacerbation of the inflammatory process, respiratory failure or migration of the filling of the 
obturator in the airways. After removal of a filling in a bronchus local changes of a mucous in the 
form of its hyperemia and edema, which were inverse character, were noted. 
In all 12 (19.1 %) cases, when the patient’s condition allowed performing surgery, this tech-
nique made it possible, after correction of homeostasis in 3–10 days, to perform it with significantly 
less risk for the patient.
Bronchial arteriography and angiopulmonography are the most reliable methods of detect-
ing the source of pulmonary hemorrhage, and therapeutic embolization of the bronchial arteries 
is one of the most effective, low-traumatic and reliable methods of stopping pulmonary bleeding. 
This method can be both independent and final, as well as the stage of preparation of the patient 
for further radical surgery. However, our studies have shown that endovascular interventions 
in the area of  the bronchial arteries in the period of bleeding, especially profuse, are extremely 
complex and require careful training both from the operational and technical point of view, and 
in terms of preparation of the patient. In this regard, we propose to use the complex measures de-
scribed above to temporarily stop the LC, including managed hypotension and bronchial filling, 
before conducting endovascular diagnostics. It provides a quiet, unlimited time, endovascular 
examination. Some authors consider the main cause of the BA cancellation in the first month 
after embolization others – not BA embolization, revascularization of the pathological focus with 
about the development of collaterals, progress congestion of the underlying disease. 
The study was conducted in 34 (53.9 %) patients, with 32 (50.8 %) patients undergoing bron-





















was done to 28 (44.4 %) patients with COPD complicated by LB. The indication for embolization of 
the bronchial artery was the detection of direct or indirect signs of bleeding during angiography. In 
13 (20.6 %) patients REO was performed at the “height of bleeding” due to inefficiency of conser-
vative hemostasis. In 5 (7.9 %) patients, REO was performed after conservative hemostasis due to 
the high risk of recurrence of hemorrhage. In 4 (6.4 %) patients with bilateral inflammatory process 
and unspecified source of pulmonary hemorrhage at bronchoscopy, the technique of delayed embo-
lization of bronchial arteries was used. All patients with unilateral localization of the pathological 
process after REO achieved a stable hemostatic effect. In the future, 14 (22.2 %) patients underwent 
routine lung surgeries within 4 to 10 days. 12 (19.1 %) patients of the main group were operated on 
and endovascular occlusion of the bronchial arteries was the main and definitive method of treat-
ment of pulmonary bleeding [26, 27].
Mortality in the main group was 1.6 % (2 patients with chronic lung abscess, which was 
complicated by p r ofuse pulmonary hemorrhage). Patients for temporary hemostasis were per-
formed REO of the left bronchial artery at the height of bleeding with subsequent pulmonectomy. 
Total recurrence of pulmonary hemorrhage was observed in 4 (6.4 %) patients. The ineffectiveness 
of conservative therapy in the comparison group served in patients with severe blood loss indica-
tions for external surgery – thoracotomy with lobo- or pulmonectomy. Planned surgical interven-
tions were performed in 10 (12.8 %) patients, 14 (17.9 %) patients were operated on urgent at the 
height of pulmonary bleeding, and 54 (69.2 %) patients were treated only conservatively.
Out of the 36 pat ients in the comparison group, 5 (6.4 %) died, with a lethal outcome in 
the group of conservatively treated outbreaks in 2 (3.7 %) patients as a result of recurrent profuse 
bleeding, and 2 (14.3 %), among planned ones – 1 (10 %) patient. Total recurrence of pulmonary 
hemorrhage was noted in 16 (29.5 %) patients.
We have developed a patent of Ukraine for utility model UA 113048 (10.01.2017) “A method 
of treatment of patients with pulmonary hemorrhage”, which includes catheterization of the femo-
ral artery, as well as the obturation of bronchial arteries, which are performed by the introduction 
of rigid emboli in combination with microspiral. This technique was performed under angiographic 
control. We have developed an advanced technique and allows for an effective prolonged stop of 
pulmonary bleeding. The problem is solved by the fact that the obstruction of the bronchial arter-
ies is carried out by introducing into them rigid emboli in combination with microspirals in the 
conditions of the angiographic department. The use of rigid emboli can block the bleeding vessel 
with elements of durable material that does not lose its shape under the pressure and influence of 
an aggressive environment. The combination of microspirals with emboli allows obtaining a dense 
conglomerate due to the partial penetration of the emboli in the microspiral, thereby realizing the 
moment of blocking of the bleeding vessel.
4. Conclusions
1. In our observations, no effective REE of bronchial arteries activity with repeated expo-
sure of LB and hemoptysis observed in 10.2 % of patients, early in 8.3 % of them. Repeated LB at 
a later timing appeared in 13.5 % of patients, which required repeated implementation of REEA. 
Causes of REE LB are different. 
2. Roentgen-endovascular embolization of bronchial arteries is the method of choice for 
the treatment of LB and hemoptysis in most patients with chronic lung diseases. The use of REE 
in cancer lung complicated by LB requires further clinical evaluation developing clear evidence. 
Additional evaluation of the effectiveness of new embolizing materials. 
3. Therefore bronchial artery angiography gives high efficiency in solving the problem 
of hemostasis in oncological and nonspecific lung diseases, for determination of localization 
and source of bleeding. Endovascular occlusion of bronchial arteries in pulmonary hemor-
rhage permits: 
– to elaborate diagnosis because of the presence of specific angiographic signs of malig-
nant tumor; 
– to perform effective endovascular hemostasis; 
– to gain time for stabilization the patient with the aim of planned surgical treatment. 
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